Estrone (E1) is a significant estrogenic marker providing crucial insights into a woman's estrogen metabolism and overall hormonal balance. Estrone, primarily a product of peripheral aromatization of androstenedione, is one of the three major naturally occurring estrogens, alongside estradiol (E2) and estriol (E3).
In premenopausal women, estrone levels typically fluctuate with the menstrual cycle, whereas in postmenopausal women, it becomes the predominant form of estrogen, primarily produced in adipose tissue.
The measurement of urinary estrone is particularly valuable as it reflects the integrated production of this hormone over time, offering a more comprehensive picture than a single blood sample. Elevated levels of estrone can be associated with conditions like polycystic ovary syndrome (PCOS), obesity, and estrogen dominance, potentially contributing to symptoms such as irregular menstrual cycles, weight gain, mood changes, and increased risk for certain types of estrogen-sensitive cancers, like breast and endometrial cancer. Conversely, low estrone levels might indicate ovarian insufficiency, hypopituitarism, or issues with estrogen synthesis.
Treatment for abnormal estrone levels typically involves addressing the underlying cause, which could include lifestyle changes like diet and exercise, management of body weight, hormonal therapies, and addressing any associated health conditions. The goal of treatment is to restore hormonal balance, alleviate symptoms, and reduce the risk of long-term health issues related to hormonal imbalance.
Regular monitoring of estrone and other hormone levels is an essential component of effective management and treatment planning.
Every lab result you’ve ever had, charted and explained.
Healthmatters is a tracker for your lab results. Upload a report from any lab, any country — every marker charted and explained.
Start with my report →All our content is backed by peer-reviewed studies, academic research, and trusted medical sources. We’re committed to accuracy and transparency — see our editorial policy for details.